Evaluation of a Power Assistance Device for Wheelchair-DUO
NCT ID: NCT03386799
Last Updated: 2022-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
27 participants
OBSERVATIONAL
2018-03-20
2021-04-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Furthermore DUO has an option with a longer assistance (AEP+) which can be preferred by some people.
To be referenced and reimbursed by the French health insurance, DUO has to be compared with an other power assistance device for wheelchairs, already referenced.
The study is a comparative study between DUO and the ALBER E Motion. Each patient is his own control and is assessed in 4 experimental conditions, with intervals of 3 or 4 days, manually propelled, with the E mtion device, with the DUO device and the single push configuration, with the DUO device and the AEP+ configuration.
The main outcome measure will be the user's satisfaction (using 8 items of the ESAT questionnaire)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determining Levels of Function Associated With Permobil SmartDrive Manual Wheelchair Assist
NCT04973059
Seated - Standing Passage of the Hemiplegic
NCT03117699
Comparison of Three Different Assisting Devices to Power Manual Wheelchairs in Patients With Spinal Cord Injury
NCT02244931
Evaluation on Standardized Circuits of the Interest of a Robotic Module of Assistance to the Driving
NCT04072536
An Assistive Powered Wheelchair: Stage 2 Trial
NCT05292690
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient in wheelchair
Patient in wheelchair with E-motion device
E-motion device
Powered assisted Wheelchair with the E-motion device. Outdoor and indoor runs
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
E-motion device
Powered assisted Wheelchair with the E-motion device. Outdoor and indoor runs
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* propelling his wheelchair with both arms or with one foot and one arm.
* covered by the French national health insurance.
* living at less than 30km form the investigation center
Exclusion Criteria
* owning already a power wheelchair or a powered assisted wheelchair
* with cognitive impairments that affect the steering capacity or the understanding of the instructions.
* Patient unable to use a manual wheelchair indoor without help,
* Contraindication in keeping a seating position especially the occurrence of ulcers.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
André Thevenon, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Swynghedauw, CHU
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A02670-53
Identifier Type: OTHER
Identifier Source: secondary_id
2016_75
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.